(Photo Courtesy: www.aimcentre.com.au)
Each year, May 20th is celebrated as International Clinical Trials Day to mark the day the world's first controlled clinical trial was conducted.
India has 17 percent of the global population and 20 percent of the global disease burden yet India's share of all clinical studies being done in the world is less than 1.4 percent.
Given that many of the regulatory challenges of the last two years have now been addressed through new amendments and orders, there is a need to rebuild the confidence of global and local stakeholders in order to strengthen clinical research in India.
As the global community commemorates another International Clinical Trials Day on May 20th, the clinical research fraternity in India opines that regulatory challenges, misconceptions about clinical trials and lack of awareness amongst the general public are the most important factors holding back the progress of clinical research in India.
The survey, which was conducted by pharmaceutical company Sanofi amongst attendees of the Annual Conference organised by the Indian Society for Clinical Research (ISCR) earlier this year, further identified the following as critical requirements: